Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 69 citing articles:

Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARα-CYP4X1 axis in colonic macrophages
Yaxin Chen, Yanzhuo Liu, Yang Wang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 138
A circular RNA derived from the insulin receptor locus protects against doxorubicin-induced cardiotoxicity
Dongchao Lu, Shambhabi Chatterjee, Ke Xiao, et al.
European Heart Journal (2022) Vol. 43, Iss. 42, pp. 4496-4511
Open Access | Times Cited: 71
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
Nabil V. Sayour, Á. Paál, Pietro Ameri, et al.
European Heart Journal (2024) Vol. 45, Iss. 14, pp. 1224-1240
Open Access | Times Cited: 18
Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth
Tal Caller, Itai Rotem, Olga Shaihov–Teper, et al.
Circulation (2024) Vol. 149, Iss. 22, pp. 1729-1748
Closed Access | Times Cited: 18
Physical Exercise: A Novel Tool to Protect Mitochondrial Health
Daniela Sorriento, Eugenio Di Vaia, Guido Iaccarino
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 75
Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer
Anja Karlstaedt, Javid J. Moslehi, Rudolf A. de Boer
Nature Reviews Cardiology (2022) Vol. 19, Iss. 6, pp. 414-425
Open Access | Times Cited: 56
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart
Jolanda van der Velden, Folkert W. Asselbergs, Jeroen Bakkers, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 15, pp. 3016-3051
Open Access | Times Cited: 54
The Innate Immune System in Cardiovascular Diseases and Its Role in Doxorubicin-Induced Cardiotoxicity
Anchit Bhagat, Pradeep Shrestha, Eugenie S. Kleinerman
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14649-14649
Open Access | Times Cited: 39
Priorities in Cardio-Oncology Basic and Translational Science
Fadi N. Salloum, Carlo G. Tocchetti, Pietro Ameri, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 6, pp. 715-731
Open Access | Times Cited: 23
Baicalin-peptide supramolecular self-assembled nanofibers effectively inhibit ferroptosis and attenuate doxorubicin-induced cardiotoxicity
Yinghua Zeng, Xu Liao, Yuting Guo, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 838-848
Closed Access | Times Cited: 11
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors
Flora Pirozzi, Remo Poto, Luisa Aran, et al.
Current Oncology Reports (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 53
LncRNA-miRNA interaction is involved in colorectal cancer pathogenesis by modulating diverse signaling pathways
Shadia Hamoud Alshahrani, Zeina S. M. Al-Hadeithi, Sami G. Almalki, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154898-154898
Closed Access | Times Cited: 16
Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond
Umberto Attanasio, Elena Di Sarro, Lucia Tricarico, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 199-199
Open Access | Times Cited: 6
PD-1/PDL-1 Inhibitors and Cardiotoxicity; Molecular, Etiological and Management Outlines
Mohammed Safi, Hyat Ahmed, Mahmoud Al‐Azab, et al.
Journal of Advanced Research (2020) Vol. 29, pp. 45-54
Open Access | Times Cited: 40
Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies
Sanne de Wit, Claire Glen, Rudolf A. de Boer, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 18, pp. 3451-3466
Open Access | Times Cited: 27
Breast cancer chemotherapy induces vascular dysfunction and hypertension through a NOX4-dependent mechanism
Piotr Szczepaniak, Mateusz Siedliński, Diana Hodorowicz‐Zaniewska, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 13
Open Access | Times Cited: 25
Cardiac Dysfunction Promotes Cancer Progression via Multiple Secreted Factors
Lama Awwad, Ami Aronheim
Cancer Research (2022) Vol. 82, Iss. 9, pp. 1753-1761
Open Access | Times Cited: 23
European Society of Cardiology Core Curriculum for cardio‐oncology
Teresa López‐Fernández, Dimitrios Farmakis, Pietro Ameri, et al.
European Journal of Heart Failure (2023) Vol. 26, Iss. 4, pp. 754-771
Open Access | Times Cited: 15
Mitochondrial dysfunction in cardiovascular disease: investigating therapeutic approaches to enhance patient outcomes
Omar Elsaka
MGM Journal of Medical Sciences (2025) Vol. 12, Iss. 1, pp. 127-135
Open Access
Advanced cancer is also a heart failure syndrome: a hypothesis
Markus S. Anker, Ana Pardo Sanz, José Luis Zamorano, et al.
European Journal of Heart Failure (2020) Vol. 23, Iss. 1, pp. 140-144
Open Access | Times Cited: 33
Cancer incidence and mortality in patients diagnosed with heart failure: results from an updated systematic review and meta-analysis
Massimiliano Camilli, Juan Guido Chiabrando, Marco Lombardi, et al.
Cardio-Oncology (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Update on preclinical models of cancer therapy‐related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio‐Oncology, and the ESC Working Group on Cellular Biology of the Heart
Alessandra Ghigo, Pietro Ameri, Aarti Asnani, et al.
European Journal of Heart Failure (2025)
Open Access
Advanced cancer is also a heart failure syndrome: a hypothesis
Markus S. Anker, Ana Pardo Sanz, José Luis Zamorano, et al.
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 3, pp. 533-537
Open Access | Times Cited: 26
Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)
Valentina Mercurio, Alessandra Cuomo, Christian Cadeddu Dessalvi, et al.
Antioxidants (2020) Vol. 9, Iss. 7, pp. 641-641
Open Access | Times Cited: 26
Infiltrating macrophages amplify doxorubicin-induced cardiac damage: role of catecholamines
Jessica Gambardella, Gaetano Santulli, Antonella Fiordelisi, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 11
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top